United States Seventh Circuit

Reset A A Font size: Print

IN RE: BRAND NAME PRESCRIPTION DRUGS ANTITRUST LITIGATION, 00-4206, 00-4264, 00-4265, 00-4266

In an action for price-fixing under the Sherman Act, plaintiffs, retail sellers of prescription drugs, failed to adequately show that the drug manufacturers conspired to fix prices and that the drug wholesalers joined the conspiracy by adopting an alleged "chargeback" system.

Appellate Information

  • Decided 05/06/2002
  • Published 05/06/2002

Judges

Court

  • United States Seventh Circuit

Counsel

Copied to clipboard